MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.1680
-0.0120 (-6.67%)
Sep 11, 2026, 5:30 PM CET

SWX:MMTX Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
1.20.64-
Revenue Growth
---
Cost of Revenue
0.120.05-
Gross Profit
1.080.59-
Selling, General & Admin
7.995.820
Research & Development
5.175.29-
Operating Expenses
13.1511.110
Operating Income
-12.07-10.52-0
Interest Expense
--0.27-
Interest & Investment Income
0.290.310
Currency Exchange Gain (Loss)
-0.530.58-
Other Non Operating Income (Expenses)
2.95-0.02-
Pretax Income
-9.36-9.91-0
Net Income
-13.54-9.91-0
Net Income to Common
-13.54-9.91-0
Net Income Growth
---
Shares Outstanding (Basic)
912113
Shares Outstanding (Diluted)
912113
Shares Change
-64.65%-
EPS (Basic)
-0.15-0.48-0.00
EPS (Diluted)
-0.15-0.48-0.00
EPS Growth
---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-16.34-13.45-0
Free Cash Flow Per Share
-0.18-0.65-
Gross Margin
90.39%92.06%-
Operating Margin
-1009.45%-1637.85%-
Profit Margin
-1132.27%-1542.99%-
Free Cash Flow Margin
-1365.89%-2094.39%-
EBITDA
-10.22-9.14-
D&A For EBITDA
1.861.37-
EBIT
-12.07-10.52-0
Revenue as Reported
1.20.64-